People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Prevounce Health, Inc. | — | Healthtech | Series A | $4.5M | $52.8M | 2022 |
| ORF Biologics, Inc. | — | Biotechnology | Seed | $2.5M | $9.5M | 2024 |
Stephen Hanson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Hanson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Kluger | 1 | 3 |
| Michael Hammond | 1 | 2 |
| Jay Kamath | 1 | 1 |
| Sara Ternes | 1 | 1 |
| Anant Kamath | 1 | 1 |
| Timothy J. Hargarten | 1 | 1 |
| Gary Tashnek | 1 | 1 |
| Daniel Tashnek | 1 | 1 |
| Steven Michalicek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.